Equity
€438,324 ▲ 11.5%
EFRAX has made a profit in every financial year since 2017.
EFRAX
Lifetime
9 annual accounts with figures on one time axispeak €81,168 (2021)
€64,423▼ 9.4%
peak €57,599 (2023)
€45,359▼ 8.1%
peak €438,324 (2025)
€438,324▲ 11.5%
€139,327▼ 14.8%
Board2 names since 2016
1 director
Documentsfilings and deeds
04-03-202657 days before the deadline
2025micro format
Investments €50,000
Key points
from the 2025 annual accountsFilings
9 annual accounts since 2017
The last five annual accounts were filed 47 to 57 days before the end of the period.
Position in the sector
€438,324
More equity than 88% of companies in pharmaceuticals. Sector median €63,492 · 88 companies.
Checked score
Outside the general model
Holding: general score not applicable
The company has a registered holding activity. Financial fixed assets make up more than half of its assets. The general model for operating companies does not fit such a balance sheet, so there is no score and no financial strength.
Bankruptcy probability within 12 months
The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0654897577
Appointment: (successor director)
Gazette deed
Incorporation
Founder: · Founding capital of €100,000, 1,200 shares · Appointment: (manager) · published on 25-05-2016 · Gazette deed
First establishment
Floris Verbraekenlei 2, Brasschaat
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| EFRAX Brasschaat | €577,651 | €64,423 | 75.9% | - |
| DCVISION Kaprijke | €443,302 | €158,650 | 47.6% | - |
| EXEL DENTAL Braine-le-Comte | €383,704 | €145,877 | 24.4% | - |
| PHARMA 2424 Charleroi | €550,405 | €195,539 | 55.3% | 1.1 |
| DENTALEX Schilde | €266,453 | €140,550 | 15.3% | - |
| PRIEKA Etterbeek | €440,325 | €41,850 | 0.6% | - |
| C&J Laboratories Belgium Sint-Niklaas | €166,880 | €77,087 | 22.4% | - |
These companies have the same main activity as EFRAX: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209). They are comparable in size and age: total assets between €167,000 and €550,000, founded between 2008 and 2020.
Official details
Source: KBO- Status
- Active since 23-05-2016Normal situation
- Activity
- Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21209and 8 others
- Establishment unit
- 2.253.464.9032930 Brasschaat, since 23-05-2016
- Financial year end
- 30 September
- Peppol
- Reachable since 05-12-2025
Annual accounts to 30-09-2025
- ≈ €190,000estimated
- €577,651▲ 3.8%
- Filing
- Filed on 04-03-2026, 57 days before the end of the filing period
Insights on EFRAX
EFRAX files the micro format. That format states no turnover. The gross margin fell from €65,625 in 2017 to €64,423 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about EFRAX
- What is the company number of EFRAX?
- The company number of EFRAX is 0654.897.577. The VAT number is the same number with BE in front: BE 0654.897.577.
- Where is EFRAX based?
- The registered office is at Floris Verbraekenlei 2, 2930 Brasschaat.Company details
- What does EFRAX do?
- According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209).
- What is the legal form of EFRAX?
- EFRAX is a private limited company (BV).
- When was EFRAX founded?
- EFRAX was founded on 23-05-2016.
- Is EFRAX still active?
- Yes, EFRAX is an active enterprise in the KBO register.
- What is the turnover of EFRAX?
- The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €64,423 and 2,666 comparable companies of the same size. It probably lies between €130,000 and €340,000. It is a rough estimate.Financials
- Is EFRAX profitable?
- In financial year 2025, EFRAX made a profit of €45,359.
- Where can I find the annual accounts of EFRAX?
- EFRAX filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of EFRAX due?
- EFRAX must file the annual accounts for financial year 2026 by 30-04-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See what changed in the latest annual accounts.What changed See this company's board, registered office and name on a given date.Company as of a date
See how customers, suppliers and banks see your own company and what to improve first.